Join us for an engaging discussion in this webinar. Together, we'll highlight how you can advance your hematology research with next generation sequencing (NGS). In this webinar, you will:
Join us for an engaging discussion in this webinar. Together, we'll highlight how you can advance your hematology research with next generation sequencing (NGS).
In this webinar, you will:
Head of Molecular Genetics,
MLL Munich Leukemia Laboratory
Manja is responsible for R&D with emphasis on NGS in leukemia diagnostics, especially on the ongoing 5,000 whole genomes projects aimed at a better understanding of leukemia’s genetics. She studied biology at the Universities of Tübingen and Munich with focus on human genetics, immunology, and bioinformatics. She received her Master of Science in Biology from the Ludwig-Maximilians-University in Munich and her PhD in collaboration with the Helmholtz Center Munich working on gene regulation within the architecture of the cell nucleus. After her post-doctorate, she moved to the field of hematology as a scientist in the department of molecular genetics at MLL. Besides leukemia diagnostics, her scientific work focuses on mutational patterns and their prognostic impact within different leukemia entities. She has published and contributed to more than 50 scientific papers in hematology in the last seven years. In combination with her MBA in Health Care Management the aim of her work is also to improve the diagnostic and prognostic work to optimize routine diagnostic approaches for patients with leukemia or lymphoma.
Manager, Strategic Marketing,
Integrated DNA Technologies
Jordan leads IDT’s account-based marketing programs and is responsible for establishing new partnerships and collaborations with institutions and researchers around the world. Prior to IDT, he held multiple positions ranging from product management to sales within cell biology, genomics, and medical devices. Jordan has a BS in Applied Biology and MBS with a focus in life sciences and biotechnology.